{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:52:18Z","timestamp":1794556338894,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022572","name":"NIHR Sheffield Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203321"],"award-info":[{"award-number":["NIHR203321"]}],"id":[{"id":"10.13039\/501100022572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101132356"],"award-info":[{"award-number":["101132356"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007453","name":"Stiftung VERUM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tjpad.2025.100096","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:31:26Z","timestamp":1739863886000},"page":"100096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-7435","authenticated-orcid":false,"given":"Robert","family":"Perneczky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-8129","authenticated-orcid":false,"given":"Takeshi","family":"Iwatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Mummery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-6679","authenticated-orcid":false,"given":"Kee Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5641-0004","authenticated-orcid":false,"given":"Johan","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-6224","authenticated-orcid":false,"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tjpad.2025.100096_bib0001","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jalz.2017.04.005","article-title":"Dementia registries around the globe and their applications: a systematic review","volume":"13","author":"Krysinska","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12874-022-01768-6","article-title":"Real-world data: a brief review of the methods, applications, challenges and opportunities","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"16","key":"10.1016\/j.tjpad.2025.100096_bib0003","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jama.2023.4855","article-title":"Randomized trials vs real-world evidence: how can both inform decision-making?","volume":"329","author":"Sheldrick","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100096_bib0004","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.tjpad.2025.100096_bib0005","unstructured":"European Medicines Agency, Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence. Available at https:\/\/www.ema.europa.eu\/en\/reflection-paper-use-real-world-data-non-interventional-studies-generate-real-world-evidence-scientific-guideline. Accessed November 2024."},{"key":"10.1016\/j.tjpad.2025.100096_bib0006","unstructured":"Food and Drug Administration, Real-world data: assessing registries to support regulatory decision-making for drug and biological products. Available at https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/real-world-data-assessing-registries-support-regulatory-decision-making-drug-and-biological-products. Accessed August 2024."},{"key":"10.1016\/j.tjpad.2025.100096_bib0007","unstructured":"Canadian Agency for Drugs and Technologies in Health, real-world evidence for decision-making. Available at https:\/\/www.cadth.ca\/real-world-evidence-decision-making. Accessed November 2024."},{"issue":"2","key":"10.1016\/j.tjpad.2025.100096_bib0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamaneurol.2023.4675","article-title":"Ownership and interoperability challenges of Alzheimer monoclonal antibody registries","volume":"81","author":"Socal","year":"2024","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00168-2022","article-title":"Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future","volume":"8","author":"Kroes","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.tjpad.2025.100096_bib0010","first-page":"16","volume":"2017","author":"Kennedy","year":"2017"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12195-023-00766-y","article-title":"Contact guidance drives upward cellular migration at the mesoscopic scale","volume":"16","author":"Chen","year":"2023","journal-title":"Cell Mol Bioeng"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0012","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer's disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100096_bib0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA,"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100096_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100068","article-title":"Use of lecanemab and donanemab in the Canadian healthcare system: evidence, challenges, and areas for future research","author":"Smith","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100096_bib0016","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s40264-019-00848-9","article-title":"Patient registries: an underused resource for Medicines Evaluation : operational proposals for increasing the use of patient registries in regulatory assessments","volume":"42","author":"McGettigan","year":"2019","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100096_bib0017","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/alz.12945","article-title":"Outcome measures for Alzheimer's disease: a global inter-societal Delphi consensus","volume":"19","author":"Ellison","year":"2023","journal-title":"Alzheimer Dement"},{"key":"10.1016\/j.tjpad.2025.100096_bib0018","unstructured":"United Nations Educational, S.a.C.O.I.f.S., International Standard Classification of Education (ISCED) 2011; Available at https:\/\/uis.unesco.org\/sites\/default\/files\/documents\/international-standard-classification-of-education-isced-2011-en.pdf. Accessed November 2024."},{"issue":"7576","key":"10.1016\/j.tjpad.2025.100096_bib0019","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/527S14a","article-title":"Deep phenotyping: the details of disease","volume":"527","author":"Delude","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s41999-020-00326-x","article-title":"Bilingualism for delaying the onset of Alzheimer's disease: a systematic review and meta-analysis","volume":"11","author":"Paulavicius","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.tjpad.2025.100096_bib0021","article-title":"Lifelong bilingualism functions as an alternative intervention for cognitive reserve against Alzheimer's disease","volume":"12","author":"Liu","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100096_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149131","article-title":"Handedness in Alzheimer's disease: a systematic review","volume":"1840","author":"Abuduaini","year":"2024","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100096_bib0023","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/00207454.2019.1707824","article-title":"Handedness of healthy elderly and patients with Alzheimer's disease","volume":"130","author":"Ryan","year":"2020","journal-title":"Int J Neurosci"},{"issue":"10452","key":"10.1016\/j.tjpad.2025.100096_bib0024","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet,"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","article-title":"Implications of sleep disturbance and inflammation for Alzheimer's disease dementia","volume":"18","author":"Irwin","year":"2019","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1570159X20666220201091006","article-title":"Impact of the cannabinoid system in Alzheimer's Disease","volume":"21","author":"Li","year":"2023","journal-title":"Curr Neuropharmacol"},{"issue":"15","key":"10.1016\/j.tjpad.2025.100096_bib0027","first-page":"24","article-title":"A brief review on the potential of psychedelics for treating Alzheimer's Disease and related depression","author":"Pilozzi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-019-0357-9","article-title":"Roles of vascular risk factors in the pathogenesis of dementia","volume":"43","author":"Takeda","year":"2020","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100096_bib0029","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100096_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp-2023-332661","article-title":"Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease","volume":"95","author":"Patel","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40842-024-00168-7","article-title":"Metformin mitigates dementia risk among individuals with type 2 diabetes","volume":"10","author":"Aderinto","year":"2024","journal-title":"Clin Diabet Endocrinol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","article-title":"Updated safety results from phase 3 lecanemab study in early Alzheimer's disease","volume":"16","author":"Honig","year":"2024","journal-title":"Alzheimer Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0033","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12877-022-03144-x","article-title":"Prevalence of oral anticoagulant use among people with and without Alzheimer's disease","volume":"22","author":"Ali Babar","year":"2022","journal-title":"BMC Geriatr"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100096_bib0034","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/nn.4393","article-title":"Multimodal population brain imaging in the UK Biobank prospective epidemiological study","volume":"19","author":"Miller","year":"2016","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100096_bib0035","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0036","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/gps.1291","article-title":"Screening for dementia in an Irish community sample using MMSE: a comparison of norm-adjusted versus fixed cut-points","volume":"20","author":"Cullen","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100096_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2318-5-7","article-title":"Brief cognitive assessment in a UK population sample - distributional properties and the relationship between the MMSE and an extended mental state examination","volume":"5","author":"Huppert","year":"2005","journal-title":"BMC Geriatr"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100096_bib0038","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1017\/S1355617711001573","article-title":"Construct validity of the Montreal Cognitive Assessment (MoCA)","volume":"18","author":"Freitas","year":"2012","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WAD.0b013e3182420bfe","article-title":"Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease","volume":"27","author":"Freitas","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10928-022-09839-3","article-title":"Characterization of exposure-clinical Dementia rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials","volume":"50","author":"Muralidharan","year":"2023","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100096_bib0041","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14283\/jpad.2020.73","article-title":"Psychometric properties of the Clinical Dementia Rating - Sum of boxes and other cognitive and functional outcomes in a prodromal alzheimer's disease population","volume":"8","author":"McDougall","year":"2021","journal-title":"J Prev Alzheimer Dis"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100096_bib0042","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0043","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jalz.2012.06.008","article-title":"Application of resource utilization in dementia (RUD) instrument in a global setting","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimer Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0044","first-page":"48","article-title":"Resource utilization in dementia: RUD Lite","volume":"3","author":"Wimo","year":"2003","journal-title":"Brain Aging"},{"key":"10.1016\/j.tjpad.2025.100096_bib0045","unstructured":"European Medicines Agency, Serious adverse reaction. Available at https:\/\/www.ema.europa.eu\/en\/glossary\/serious-adverse-reaction. Accessed November 2024."},{"key":"10.1016\/j.tjpad.2025.100096_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.7548","article-title":"Conveying risks of harm in Alzheimer disease by amyloid lowering","author":"Thambisetty","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-150685","article-title":"Excess costs associated with possible misdiagnosis of Alzheimer's disease among patients with vascular dementia in a UK CPRD population","volume":"53","author":"Happich","year":"2016","journal-title":"J Alzheimer Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0048","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00006842-200205000-00016","article-title":"Assessing quality of life in older adults with cognitive impairment","volume":"64","author":"Logsdon","year":"2002","journal-title":"Psychosom Med"},{"key":"10.1016\/j.tjpad.2025.100096_bib0049","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12955-016-0493-8","article-title":"Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients","volume":"14","author":"Torisson","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol -a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100096_bib0051","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11136-017-1777-0","article-title":"An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care","volume":"27","author":"Easton","year":"2018","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0052","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13195-018-0414-7","article-title":"Utility of the dependence Scale in dementia: validity, meaningfulness, and health economic considerations","volume":"10","author":"Zhu","year":"2018","journal-title":"Alz Res Ther"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100096_bib0053","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/geront\/20.6.649","article-title":"Relatives of the impaired elderly: correlates of feelings of burden","volume":"20","author":"Zarit","year":"1980","journal-title":"Gerontologist"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0054","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/geront\/26.3.260","article-title":"Subjective burden of husbands and wives as caregivers: a longitudinal study","volume":"26","author":"Zarit","year":"1986","journal-title":"Gerontologist"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100096_bib0055","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jalz.2014.10.006","article-title":"The sensitivity to change over time of the Amsterdam IADL Questionnaire","volume":"11","author":"Koster","year":"2015","journal-title":"Alzheimer Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0056","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000346277","article-title":"Validation of the Amsterdam IADL Questionnaire\u00a9, a new tool to measure instrumental activities of daily living in dementia","volume":"41","author":"Sikkes","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0057","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0891988713509139","article-title":"Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living questionnaire","volume":"26","author":"Sikkes","year":"2013","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0058","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12877-022-03527-0","article-title":"Psychometric properties of the Alzheimer's Disease Cooperative Study \u2013 activities of daily living for mild cognitive impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial","volume":"23","author":"Potashman","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.tjpad.2025.100096_bib0059","first-page":"38","article-title":"How to improve access to medical imaging in low- and middle-income countries ?","author":"Frija","year":"2021","journal-title":"eClin Med"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100096_bib0060","doi-asserted-by":"crossref","first-page":"e5022","DOI":"10.1002\/nbm.5022","article-title":"MRI scarcity in low- and middle-income countries","volume":"36","author":"Jalloul","year":"2023","journal-title":"NMR Biomed"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100096_bib0061","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/alz.12782","article-title":"Alzheimer's Association launches ALZ-NET: a long-term data collection and sharing network for new treatments","volume":"18","year":"2022","journal-title":"Alzheimer Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100096_bib0062","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer's Coordinating Center's uniform data set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.tjpad.2025.100096_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2023.100424","article-title":"The role of real-world data and evidence in oncology medicines approved in EU in 2018-2019","volume":"36","author":"Eskola","year":"2023","journal-title":"J Cancer Policy"},{"key":"10.1016\/j.tjpad.2025.100096_bib0064","article-title":"Evaluation of real-world tumor response derived from electronic health record data sources: a feasibility analysis in patients with metastatic non-small cell lung cancer treated with chemotherapy","volume":"8","author":"McKelvey","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"issue":"17","key":"10.1016\/j.tjpad.2025.100096_bib0065","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2022.02.034","article-title":"The National Cardiovascular Data Registry Data Quality Program 2020: JACC state-of-the-art review","volume":"79","author":"Malenka","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100096_bib0066","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.94.9.2341","volume":"94","author":"Ryan","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100096_bib0067","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13300-023-01525-y","article-title":"Real-world use of oral semaglutide in adults with type 2 diabetes: the PIONEER REAL Switzerland Multicentre, prospective, observational study","volume":"15","author":"Kick","year":"2024","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0068","doi-asserted-by":"crossref","first-page":"e12268","DOI":"10.1002\/trc2.12268","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimer Dement (N Y)"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100096_bib0069","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1002\/alz.14313","article-title":"Associations of semaglutide with first-time diagnosis of Alzheimer\u2019s disease in patients with type 2 diabetes: target trial emulation using nationwide real-world data in the US","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimer Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100096_bib0070","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200328","article-title":"Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies","volume":"11","author":"Yeh","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100096_bib0071","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1007\/s00415-024-12518-7","article-title":"A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic","volume":"271","author":"Lal","year":"2024","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100096_bib0072","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/jnnp-2023-333307","article-title":"Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study","volume":"95","author":"Dekeyser","year":"2024","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100096_bib0073","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-3774-6_1","article-title":"Blood-based biomarkers for early Alzheimer's Disease diagnosis in real-world settings","volume":"2785","author":"Perneczky","year":"2024","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100096_bib0074","doi-asserted-by":"crossref","first-page":"230","DOI":"10.14283\/jpad.2023.99","article-title":"Association of blood MicroRNA expression and polymorphisms with cognitive and biomarker changes in older adults","volume":"11","author":"Sadlon","year":"2024","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:59:32Z","timestamp":1784149172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2274580725000408"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100096","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.12.25320418","asserted-by":"object"}]},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100096"}}